Anti-invasion drugs
- PMID: 8825129
- DOI: 10.1007/BF01803790
Anti-invasion drugs
Abstract
Most of the pharmaceuticals in clinical practice today for treatment of breast and other cancers are cytotoxic or cytostatic inhibitors of tumor growth. While this type of drug has found its place, along with surgery and radiotherapy, in treatment of disease, the breast cancer death rate has not decreased. This appears to be the result of rising incidence, resistance to therapy, and metastasis of the disease. Since distant metastasis (usually indicated by lymph node involvement) of breast cancer is related only indirectly to tumor size, it would appear that a concerted effort should be made to discover drugs which directly interfere with this complex process. Metastasis appears to depend upon tumor cell motility, dedifferentiation, local invasion, and angiogenesis. Significant progress has been recently made in the creation of new animal models of metastasis and in identifying several new drugs which may be suitable for clinical inhibition of this process. This article reviews current findings on anti-invasion/metastasis drugs with a focus on breast cancer.
Similar articles
-
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.Breast Cancer Res. 2016 Dec 8;18(1):125. doi: 10.1186/s13058-016-0781-6. Breast Cancer Res. 2016. PMID: 27931239 Free PMC article.
-
Discovery and evaluation of nNav1.5 sodium channel blockers with potent cell invasion inhibitory activity in breast cancer cells.Bioorg Med Chem. 2018 May 15;26(9):2428-2436. doi: 10.1016/j.bmc.2018.04.003. Epub 2018 Apr 3. Bioorg Med Chem. 2018. PMID: 29673714 Free PMC article.
-
Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.J Gene Med. 2005 Feb;7(2):145-57. doi: 10.1002/jgm.645. J Gene Med. 2005. PMID: 15546163
-
[Recent progress in the development of anti-tumor metastatic drugs].Gan To Kagaku Ryoho. 1995 Apr;22(5):585-91. Gan To Kagaku Ryoho. 1995. PMID: 7536403 Review. Japanese.
-
Inhibition of malignant tumor cell invasion: an approach to anti-progression.Basic Life Sci. 1993;61:335-50. doi: 10.1007/978-1-4615-2984-2_32. Basic Life Sci. 1993. PMID: 7508226 Review. No abstract available.
Cited by
-
Attacking breast cancer at the preinvasion stage by targeting autophagy.Womens Health (Lond). 2013 Mar;9(2):157-70. doi: 10.2217/whe.13.5. Womens Health (Lond). 2013. PMID: 23477322 Free PMC article.
-
Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design.Planta Med. 2009 Apr;75(5):501-7. doi: 10.1055/s-0029-1185340. Epub 2009 Feb 23. Planta Med. 2009. PMID: 19235683 Free PMC article.
-
Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells.Br J Cancer. 1999 Oct;81(3):393-403. doi: 10.1038/sj.bjc.6690707. Br J Cancer. 1999. PMID: 10507762 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical